Baytacare Pharmaceutical Co., Ltd. announced unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2017. For the quarter, the company reported turnover of RMB 1,993,000 against RMB 18,681,000 a year ago. Operating loss was RMB 5,469,000 against RMB 1,444,000 a year ago. Loss before taxation was RMB 5,648,000 against RMB 1,394,000 a year ago. Loss after taxation was RMB 15,406,000 or 1.76 cents per basic share against RMB 5,716,000 or 0.79 cents per basic share a year ago. For the nine months, the company reported turnover of RMB 17,087,000 against RMB 18,681,000 a year ago. Operating loss was RMB 14,620,000 against RMB 5,589,000 a year ago. Loss before taxation was RMB 15,406,000 against RMB 5,550,000 a year ago. Loss after taxation was RMB 5,648,000 or 0.64 cents per basic share against RMB 1,228,000 or 0.19 cents per basic share a year ago.